Heba Mohamed Zaki

Cooperative Modulation of the NF‐κB and p53 Pathways by Metronomic Cyclophosphamide and Metformin Inhibits Ehrlich Carcinoma Progression and Enhances Systemic Immunity

This study investigates the cooperative antitumor potential of combining metronomic cyclophosphamide (MTm-CTX) with the metabolic modifier metformin (MET) in a murine model of mammary carcinoma. While metronomic chemotherapy offers a reduced toxicity profile, its efficacy as a mo...